Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Amneal Posts Second Guidance Raise Of The Year Ahead Of Q3 Earnings Report
Firm Anticipates Almost $2.5bn In Net Revenue For The Year
Oct 31 2023
•
By
Chloe Kent
Amneal anticipates annual net revenue between $2.37bn and $2.42bn • Source: Shutterstock
More from Earnings
More from Business